Skip to main content
. 2020 Mar 9;180(5):718–726. doi: 10.1001/jamainternmed.2020.0193

Figure 1. Cumulative Incidence of All-Cause Mortality by Angiotensin-Converting Enzyme Inhibitor (ACE-I) and Angiotensin II Receptor Blocker (ARB) Discontinuation Status.

Figure 1.

eGFR indicates estimated glomerular filtration rate.